The role of standby emergency medication for falciparum malaria: current opinion

Prevention of influenza among travellers attending at a UK travel clinic: beliefs and perceptions. A cross‐sectional study

“…Consideration should be given where considered clinically appropriate, to travellers being provided with antivirals to carry with them on a stand‐by basis; traveller acceptance of this strategy is likely to be improved by explanation that influenza can be a severe illness. A particular consideration would be a caution with the prescription of stand‐by antivirals for travellers to malarious areas, 47 given that malaria may present as influenza‐like illness: seasonality and destination would need consideration by the prescribing practitioner. Support for this strategy comes from a recent study conducted in business travellers, which detected good knowledge of the transmission and symptoms of influenza; interestingly, 9·7% of travellers in this study acknowledged having carried antiviral medication on their last business trip, with 7·0% of travellers having actually used the carried medication 42 …”

Malaria: current prophylaxis options

“…In such instances the traveller must be counselled on the symptoms of malaria, and informed that ESBM is not a substitute for expert medical care, but merely an emergency measure that may buy time in situations where care is not immediately available. 13 Options include quinine and Malanil.…”

Standby emergency treatment of malaria for travellers to low transmission destinations. Does it make sense or save lives?

“…For this particular indication, no consensus was achieved amongst the small group for its value and role in low transmission environment, in part for the lack of evidence. [5] Subsequently the use of SBET expanded to be used through much of S. America and S. E. Asia by the Swiss, Germans and Austrians [6] with other EU countries including Italy and the Netherlands (L Visser personal communication) beginning to transition their recommendations from chemoprophylaxis to SBET in low transmission/ P vivax In S.E Asia and S America. The prescribing and carriage of SBET has been rationalised with a number of explanations.…”

“…The prescribing and carriage of SBET has been rationalised with a number of explanations. [5]  Areas have inadequate medical services, and good quality medication may not be obtainable  Remote areas out of reach of medical attention within 24 h 2 02/05/2017 16:33:00  Tolerability of chemoprophylaxis.  Reminder to travellers they are at risk of malaria and to seek medical advice if febrile  Prevent progression of/to life-threatening illness.…”